These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19056750)

  • 1. Paradoxical effect of 1-(1-naphthylmethyl)-piperazine on resistance to tetracyclines in multidrug-resistant Acinetobacter baumannii.
    Bean DC; Wareham DW
    J Antimicrob Chemother; 2009 Feb; 63(2):349-52. PubMed ID: 19056750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 1-(1-Naphtylmethyl)-piperazine, an efflux pump inhibitor, on antimicrobial drug susceptibilities of clinical Acinetobacter baumannii isolates.
    Coban AY; Guney AK; Tanriverdi Cayci Y; Durupinar B
    Curr Microbiol; 2011 Feb; 62(2):508-11. PubMed ID: 20717673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.
    Navon-Venezia S; Leavitt A; Carmeli Y
    J Antimicrob Chemother; 2007 Apr; 59(4):772-4. PubMed ID: 17353223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-beta-naphthylamide.
    Pannek S; Higgins PG; Steinke P; Jonas D; Akova M; Bohnert JA; Seifert H; Kern WV
    J Antimicrob Chemother; 2006 May; 57(5):970-4. PubMed ID: 16531429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii.
    Rumbo C; Gato E; López M; Ruiz de Alegría C; Fernández-Cuenca F; Martínez-Martínez L; Vila J; Pachón J; Cisneros JM; Rodríguez-Baño J; Pascual A; Bou G; Tomás M; ; ;
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5247-57. PubMed ID: 23939894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii.
    Seifert H; Stefanik D; Sutcliffe JA; Higgins PG
    Int J Antimicrob Agents; 2018 Jan; 51(1):62-64. PubMed ID: 28705668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.
    Liu JW; Wang LS; Cheng YJ; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Chuang YC; Lin HC; Shi ZY; Kung HC; Huang CH; Tsao SM; Lu CT; Liao CH; Hsueh PR
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Activity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii.
    Livermore DM; Mushtaq S; Warner M; Woodford N
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3840-4. PubMed ID: 27044556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative assessment of antimicrobial susceptibility testing for tigecycline and colistin against Acinetobacter baumannii clinical isolates, including multidrug-resistant isolates.
    Piewngam P; Kiratisin P
    Int J Antimicrob Agents; 2014 Nov; 44(5):396-401. PubMed ID: 25442358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936).
    Henwood CJ; Gatward T; Warner M; James D; Stockdale MW; Spence RP; Towner KJ; Livermore DM; Woodford N
    J Antimicrob Chemother; 2002 Mar; 49(3):479-87. PubMed ID: 11864948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Minocycline Susceptibility Testing Methods for Carbapenem-Resistant Acinetobacter baumannii.
    Wang P; Bowler SL; Kantz SF; Mettus RT; Guo Y; McElheny CL; Doi Y
    J Clin Microbiol; 2016 Dec; 54(12):2937-2941. PubMed ID: 27629901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumannii.
    Kuo HY; Chang KC; Kuo JW; Yueh HW; Liou ML
    Int J Antimicrob Agents; 2012 Jan; 39(1):33-8. PubMed ID: 21996406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced susceptibility of multidrug-resistant Acinetobacter baumannii to tigecycline in combination with 1-(1-naphthylmethyl)-piperazine is not a pH-dependent phenomenon.
    Wareham DW; Gordon NC; Casals JB; Bean DC
    J Antimicrob Chemother; 2009 May; 63(5):1075-6. PubMed ID: 19279048
    [No Abstract]   [Full Text] [Related]  

  • 14. AdeRS combination codes differentiate the response to efflux pump inhibitors in tigecycline-resistant isolates of extensively drug-resistant Acinetobacter baumannii.
    Sun JR; Perng CL; Lin JC; Yang YS; Chan MC; Chang TY; Lin FM; Chiueh TS
    Eur J Clin Microbiol Infect Dis; 2014 Dec; 33(12):2141-7. PubMed ID: 24939621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii.
    Hornsey M; Ellington MJ; Doumith M; Thomas CP; Gordon NC; Wareham DW; Quinn J; Lolans K; Livermore DM; Woodford N
    J Antimicrob Chemother; 2010 Aug; 65(8):1589-93. PubMed ID: 20554571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unexpected tigecycline resistance among Acinetobacter baumannii Isolates: high minor error rate by Etest.
    Kulah C; Celebi G; Aktas E; Mengeloglu Z; Comert F; Ankarali H
    J Chemother; 2009 Aug; 21(4):390-5. PubMed ID: 19622456
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Huband MD; Mendes RE; Pfaller MA; Lindley JM; Strand GJ; Benn VJ; Zhang J; Li L; Zhang M; Tan X; Liu Q; Flamm RK
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased susceptibility to tigecycline in Acinetobacter baumannii mediated by a mutation in trm encoding SAM-dependent methyltransferase.
    Chen Q; Li X; Zhou H; Jiang Y; Chen Y; Hua X; Yu Y
    J Antimicrob Chemother; 2014 Jan; 69(1):72-6. PubMed ID: 23928024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of extensive drug resistant Acinetobacter baumannii (XDRAB) at Security Forces Hospital (SFH) in Kingdom of Saudi Arabia (KSA).
    Al-Obeid S; Jabri L; Al-Agamy M; Al-Omari A; Shibl A
    J Chemother; 2015 Jun; 27(3):156-62. PubMed ID: 25867622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal spread of multidrug-resistant Acinetobacter baumannii in eastern Taiwan.
    Chang KC; Lin MF; Lin NT; Wu WJ; Kuo HY; Lin TY; Yang TL; Chen YC; Liou ML
    J Microbiol Immunol Infect; 2012 Feb; 45(1):37-42. PubMed ID: 22154678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.